A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Chemotherapy followed by donor lymphocyte infusion (DLI) is a promising treatment for relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the best strategy for administering this therapy is still uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yan, Wang, Lijun, Zhu, Chengying, Li, Honghua, Bo, Jian, Zhang, Ran, Lu, Ning, Wu, Yongli, Gao, Xiaoning, Dou, Liping, Liu, Daihong, Gao, Chunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832090/
https://www.ncbi.nlm.nih.gov/pubmed/36625951
http://dx.doi.org/10.1007/s12032-022-01911-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832090/
https://www.ncbi.nlm.nih.gov/pubmed/36625951
http://dx.doi.org/10.1007/s12032-022-01911-9

Ejemplares similares